CHEMOTHERAPY OF PROTOZOAL INFECTIONS (EXCLUDING MALARIA) - GAPS REMAIN

Authors
Citation
Ls. Garcia, CHEMOTHERAPY OF PROTOZOAL INFECTIONS (EXCLUDING MALARIA) - GAPS REMAIN, Current opinion in infectious diseases, 8(6), 1995, pp. 461-465
Citations number
NO
Categorie Soggetti
Infectious Diseases
ISSN journal
09517375
Volume
8
Issue
6
Year of publication
1995
Pages
461 - 465
Database
ISI
SICI code
0951-7375(1995)8:6<461:COPI(M>2.0.ZU;2-S
Abstract
This past year has seen advances in the treatment of certain opportuni stic protozoal infections in the immunocompromised patient, particular ly microsporidiosis. Therapy for Pneumocystis carinii pneumonia is pre sented, although this organism has been tentatively reclassified with the fungi. Management of cryptosporidiosis remains difficult, at best, and some diseases such as leishmaniasis still present specific challe nges for the clinician. Updated information will include Acanthamoeba and Cyclospora cayetanensis.